Exact sciences corporation (EXAS)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Revenue

1,062,071

876,293

723,699

623,185

526,209

454,462

398,887

353,170

307,922

265,989

213,824

169,365

132,904

99,376

78,555

63,072

50,006

39,437

26,521

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Product royalty fees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

License fees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

294

1,330

2,366

3,402

4,144

0

0

0

-

-

-

-

-

-

-

-

0

0

Total revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,798

1,330

0

0

0

-

-

-

4,144

4,150

4,153

4,159

4,163

4,477

4,752

0

0

0

Gross margin

-

-

-

-

-

-

-

-

-

186,793

144,258

108,354

79,787

54,181

39,558

28,721

20,658

14,936

6,286

258

-2,767

-2,527

406

0

0

0

-

-

-

4,144

4,144

4,141

4,141

4,139

4,453

4,728

0

0

0

Cost of sales (exclusive of amortization of acquired intangible assets)

255,496

216,717

184,128

161,478

136,892

116,644

102,312

93,356

84,794

79,196

69,566

61,011

53,117

45,195

38,997

34,351

29,348

24,501

20,235

13,631

0

0

0

-

-

-

-

-

-

-

-

-

-

24

24

24

0

0

0

Research and development

151,418

139,694

117,171

99,857

84,366

67,285

59,260

53,585

48,841

42,139

36,546

32,446

31,349

33,473

35,756

37,994

37,469

33,914

29,541

28,751

27,810

28,669

30,390

28,299

27,582

27,678

31,404

34,913

40,658

42,131

39,364

34,983

27,978

21,968

16,931

12,944

0

0

0

Sales and marketing

461,986

385,176

342,098

320,738

286,979

249,448

213,302

186,234

168,531

153,924

143,803

132,343

125,916

112,826

104,264

101,035

91,327

82,140

75,265

65,403

50,976

38,908

26,741

15,139

12,275

9,578

8,500

7,891

5,920

4,755

4,025

3,834

3,154

2,857

2,078

1,593

0

0

0

General and administrative

402,518

352,333

264,182

230,403

206,291

178,016

155,351

139,421

124,501

109,040

96,940

86,469

79,144

76,898

71,264

66,404

62,803

57,950

52,711

46,273

38,820

30,435

23,497

18,189

15,587

13,649

12,777

11,638

10,403

9,900

9,291

8,695

8,132

8,137

7,727

7,115

0

0

0

Amortization of acquired intangible assets

38,614

16,035

2,990

2,844

2,698

2,540

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

1,310,152

1,110,075

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

98,012

80,628

61,627

55,444

50,905

0

0

0

-

-

-

-

-

-

-

-

0

0

Loss from operations

-247,961

-233,662

-186,870

-192,135

-191,017

-159,471

-133,144

-120,630

-119,347

-118,310

-133,031

-142,904

-156,622

-169,016

-171,726

-176,712

-170,941

-159,068

-151,231

-140,169

-120,373

-100,539

-80,222

-59,261

-52,042

-46,761

-48,537

-50,298

-52,837

-52,642

-48,536

-43,371

-35,123

-28,823

-22,283

-16,924

0

0

0

Other income (expense)
Investment income, net

19,972

26,530

29,738

26,937

24,185

21,203

16,202

11,244

7,010

3,932

3,204

2,405

2,147

2,018

1,917

1,747

1,515

1,271

930

725

678

542

488

431

340

316

294

258

262

262

226

234

197

169

150

87

0

0

0

Interest expense

-64,762

-61,599

-58,883

-56,378

-52,269

-36,789

-25,868

-15,215

-6,666

-206

-207

-210

-209

-213

-223

-209

-49

-6

67

95

-25

1

6

34

65

69

73

68

55

41

27

21

21

21

20

20

0

0

0

Total other income (expense)

-44,790

-35,069

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

491

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss before tax

-292,751

-268,731

-216,015

-221,576

-219,101

-175,057

-142,810

-124,601

-119,003

-114,584

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income tax benefit

-186,088

-184,888

-253

-909

-467

92

129

-129

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-106,631

-83,873

-215,792

-220,697

-218,664

-175,149

-142,939

-124,472

-118,875

-114,397

-129,803

-140,709

-154,684

-167,211

-170,032

-175,174

-169,475

-157,803

-150,256

-139,371

-119,742

-100,048

-79,790

-58,890

-51,767

-46,514

-48,316

-50,108

-52,630

-52,421

-48,337

-43,158

-34,947

-28,675

-22,153

-16,857

0

0

0

Net loss per share - basic and diluted (in usd per share)

-0.71

0.62

-0.31

-0.29

-0.66

-0.44

-0.37

-0.30

-0.33

-0.18

-0.23

-0.27

-0.32

-0.34

-0.36

-0.46

-0.49

-0.41

-0.45

-0.44

-0.40

-0.38

-0.39

-0.24

-0.23

-0.17

-0.16

-0.19

-0.17

-0.22

-0.21

-0.26

-0.19

-0.18

-0.15

-0.13

-0.08

-0.08

-0.06

Weighted average common shares outstanding - basic and diluted (in shares)

148,151

139,996

129,586

129,198

126,248

122,981

122,671

122,129

121,016

119,950

119,215

112,847

110,582

109,274

104,807

97,902

97,246

96,404

94,444

88,919

88,662

84,734

82,941

82,048

70,987

70,757

70,559

64,699

63,836

63,582

60,531

57,037

56,718

53,647

52,443

52,010

51,930

-

-

Weighted average common shares outstanding-basic (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

40,155

39,067

Weighted average common shares outstanding-diluted (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

40,155

39,067